Financhill
Back

Xcelerate 10K Form

Buy
53

XCRT
Xcelerate

Last Price:
$0.0200
Seasonality Move:
38.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XCRT News And Ratings

See the #1 stock for the next 7 days that we like better than XCRT

XCRT Financial Statistics

Sales & Book Value

Annual Sales: $2.6M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $2.3M
Return on Equity: 0%
Return on Assets: 0%

Xcelerate Earnings Forecast

Key Xcelerate Financial Ratios

  • The Gross Profit Margin over the past 4 years for XCRT is 87.28%.
  • The Selling, General & Administrative Expenses for XCRT have been equal to 109.39% of Gross Profit Margin.
  • The Net Earning history of XCRT is -34.10% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Xcelerate Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: XCRT
Website: xcelerate.global

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XCRT Technical Analysis vs Fundamental Analysis

Buy
53
Xcelerate (XCRT) is a Buy

Is Xcelerate a Buy or a Sell?

  • Xcelerate stock is rated a Buy
    The current Xcelerate [XCRT] share price is $0.0195. The Score for XCRT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.